Hemogenyx Pharmaceuticals Plc
HOPHF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $4 | $3 | $0 | $0 |
| - Cash | $0 | $0 | $2 | $1 |
| + Debt | $3 | $3 | $3 | $3 |
| Enterprise Value | $7 | $6 | $1 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$6 | -$2 | -$3 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$7 | -$6 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.94 | -1 | -0.92 | -0.78 |
| % Growth | -94% | -8.7% | -17.9% | – |
| Operating Cash Flow | -$5 | -$2 | -$0 | -$3 |
| Capital Expenditures | -$0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$5 | -$2 | -$0 | -$3 |